Profound Medical Corp Stock Performance
| PROF Stock | USD 7.63 0.23 2.93% |
Profound Medical holds a performance score of 16 on a scale of zero to a hundred. The company holds a Beta of 2.79, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Profound Medical will likely underperform. Use Profound Medical value at risk, as well as the relationship between the skewness and day median price , to analyze future returns on Profound Medical.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Profound Medical Corp are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent basic indicators, Profound Medical reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (2.93) | Five Day Return 3.25 | Year To Date Return (3.42) | Ten Year Return (21.42) | All Time Return (21.42) |
Last Split Factor 1:10 | Dividend Date 2019-10-16 | Last Split Date 2019-10-16 |
1 | Profound Medical Corp. stock trendline breakdown - 2025 Analyst Calls Low Risk High Reward Ideas - newser.com | 09/29/2025 |
2 | Why retail investors favor Profound Medical Corp. stock - Weekly Trend Report Risk Adjusted Swing Trade Ideas - newser.com | 10/28/2025 |
3 | Will Profound Medical Corp. stock gain from strong economy - Earnings Beat Risk Controlled Swing Trade Alerts - newser.com | 10/31/2025 |
4 | Will Profound Medical Corp. stock deliver long term returns - 2025 Support Resistance Weekly Momentum Stock Picks - newser.com | 11/06/2025 |
5 | Profound Medical Corp Q3 2025 Earnings Report Preview What To Look For | 11/12/2025 |
6 | Wall Street Analysts Believe Profound Medical Could Rally 97.59 percent Heres is How to Trade | 11/19/2025 |
7 | Profound Medical Forms Hammer Chart Pattern Time for Bottom Fishing | 11/24/2025 |
8 | Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO Clinical Data, at RSNA and SUO Meetings | 11/28/2025 |
9 | Optimized Trading Opportunities - news.stocktradersdaily.com | 12/08/2025 |
10 | Is Profound Medical Corp. stock a safe buy before earnings - 2025 Winners Losers Verified Momentum Stock Alerts - | 12/18/2025 |
Profound Medical Relative Risk vs. Return Landscape
If you would invest 430.00 in Profound Medical Corp on September 21, 2025 and sell it today you would earn a total of 333.00 from holding Profound Medical Corp or generate 77.44% return on investment over 90 days. Profound Medical Corp is currently generating 1.0126% in daily expected returns and assumes 4.8583% risk (volatility on return distribution) over the 90 days horizon. In different words, 43% of stocks are less volatile than Profound, and 80% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Profound Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Profound Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Profound Medical Corp, and traders can use it to determine the average amount a Profound Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2084
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PROF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Profound Medical is performing at about 16% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Profound Medical by adding it to a well-diversified portfolio.
Profound Medical Fundamentals Growth
Profound Stock prices reflect investors' perceptions of the future prospects and financial health of Profound Medical, and Profound Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Profound Stock performance.
| Return On Equity | -1.24 | ||||
| Return On Asset | -0.62 | ||||
| Profit Margin | (2.75) % | ||||
| Operating Margin | (1.69) % | ||||
| Current Valuation | 211.88 M | ||||
| Shares Outstanding | 30.19 M | ||||
| Price To Book | 7.38 X | ||||
| Price To Sales | 16.87 X | ||||
| Revenue | 10.17 M | ||||
| Gross Profit | 10.36 M | ||||
| EBITDA | (25.59 M) | ||||
| Net Income | (27.82 M) | ||||
| Cash And Equivalents | 46.21 M | ||||
| Cash Per Share | 2.21 X | ||||
| Total Debt | 5.12 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 17.36 X | ||||
| Book Value Per Share | 1.06 X | ||||
| Cash Flow From Operations | (23.45 M) | ||||
| Earnings Per Share | (1.32) X | ||||
| Market Capitalization | 241.14 M | ||||
| Total Asset | 70.23 M | ||||
| Retained Earnings | (245.17 M) | ||||
| Working Capital | 62.5 M | ||||
| Current Asset | 9 K | ||||
| Current Liabilities | 761 K | ||||
About Profound Medical Performance
By analyzing Profound Medical's fundamental ratios, stakeholders can gain valuable insights into Profound Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Profound Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Profound Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 581.21 | 458.88 | |
| Return On Tangible Assets | (0.40) | (0.42) | |
| Return On Capital Employed | (0.52) | (0.55) | |
| Return On Assets | (0.40) | (0.42) | |
| Return On Equity | (0.46) | (0.48) |
Things to note about Profound Medical Corp performance evaluation
Checking the ongoing alerts about Profound Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Profound Medical Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Profound Medical appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 10.17 M. Net Loss for the year was (27.82 M) with profit before overhead, payroll, taxes, and interest of 10.36 M. | |
| Profound Medical Corp currently holds about 46.21 M in cash with (23.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.21. | |
| Profound Medical has a frail financial position based on the latest SEC disclosures | |
| Roughly 17.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Is Profound Medical Corp. stock a safe buy before earnings - 2025 Winners Losers Verified Momentum Stock Alerts - |
- Analyzing Profound Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Profound Medical's stock is overvalued or undervalued compared to its peers.
- Examining Profound Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Profound Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Profound Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Profound Medical's stock. These opinions can provide insight into Profound Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Profound Stock analysis
When running Profound Medical's price analysis, check to measure Profound Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Profound Medical is operating at the current time. Most of Profound Medical's value examination focuses on studying past and present price action to predict the probability of Profound Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Profound Medical's price. Additionally, you may evaluate how the addition of Profound Medical to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |